UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000007723 |
|---|---|
| Receipt number | R000008620 |
| Scientific Title | Phase 1 safety trial of bortezomib-based graft-versus-host disease prophylaxis in allogeneic hematopoietic stem cell transplantation from an HLA-mismatched unrelated donor in the Japan marrow donor program (JMDP) |
| Date of disclosure of the study information | 2012/04/15 |
| Last modified on | 2019/03/31 15:01:01 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2012/04/10 18:01:26 | ||
| 2 | Update | 2012/11/12 11:52:37 | Anticipated trial start date |
|
| 3 | Update | 2013/09/20 16:30:28 | Email Last name of contact person Last name of contact person Division name Division name Address Address |
|
| 4 | Update | 2018/12/05 11:32:08 | Name of primary person or sponsor Institute Department Organization |
|
| 5 | Update | 2018/12/05 11:32:54 | Recruitment status |
|
| 6 | Update | 2019/03/31 15:01:01 | Recruitment status Date of IRB Last follow-up date |
